Transposon Vector Gene Integration in CHO Cells

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing recombinant proteins in mammalian cells are inefficient and labor-intensive, with challenges in achieving high productivity and stability, particularly in Chinese hamster ovary (CHO) cells, which are crucial for pharmaceutical applications, and existing transposon systems face limitations in vertebrate animal cells.

Innovation Solution

A method involving the introduction of a protein expression vector with a gene fragment encoding the protein of interest and transposon sequences into suspension mammalian cells, integrating the gene fragment between transposon sequences into the chromosome, and using a transposase to facilitate expression, enabling efficient production of recombinant proteins.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional expression vectors are used to introduce genes into mammalian cells, then the process is well-established and relatively simple, but productivity is low and the time required to establish a production cell line is long

Engineering Contradiction:
Improveprotein production efficiencyVSAvoidtime to establish production cell line
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The patent introduces transposon sequences as intermediary elements that facilitate efficient gene integration into mammalian cell chromosomes. The transposon system acts as a mediator between the expression vector and the host genome, enabling rapid and stable integration of the gene of interest, thereby significantly reducing the time required to establish productive cell lines while maintaining high protein expression levels

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent employs preliminary selection strategies where cells are pre-selected for successful transposon integration before being used for protein production. By implementing selection markers and preliminary screening steps, the method ensures that only cells with proper gene integration proceed to production, thereby accelerating the overall process of establishing productive cell lines

Inventive Principle:
Principle #10Preliminary action

2Productivity

If transposon sequences are introduced to improve gene integration efficiency, then productivity increases, but the system becomes more complex and may face stability issues

Engineering Contradiction:
Improvegene integration efficiencyVSAvoidvector system complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent divides the expression vector system into distinct functional modules: transposon sequences for integration, expression cassette for protein production, and selection markers for screening. This segmentation allows each component to be optimized independently and facilitates systematic troubleshooting, thereby managing complexity while maintaining high integration efficiency

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent designs the transposon-based vector system to be universally applicable to multiple mammalian cell types and various genes of interest. The modular construction allows the same basic vector backbone to be used for different proteins and cell lines, reducing the need for developing new systems and managing overall system complexity

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Stability of the object's composition

If conventional cloning methods are used, then the process is straightforward, but the stability of introduced genes in mammalian cells is poor

Engineering Contradiction:
Improvegene stability in mammalian cellsVSAvoidease of establishing expression system
Core Design Contradiction:
Stability of the object's compositionVSEase of manufacture

Solution Approach 1:

The transposon sequences serve as stable intermediary elements that mediate permanent integration of the gene of interest into the mammalian cell genome. This integration ensures long-term stability of gene expression across cell divisions, overcoming the instability associated with transient transfection methods while maintaining relative ease of implementation through established transposon protocols

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for the efficient and high-level expression of proteins in mammalian cells, particularly in CHO cells, enhancing productivity and reducing the time required to establish a protein production system, thereby addressing the limitations of existing methods.

Implementation Method 1

integrating the gene fragment inserted between a pair of the transposon sequences into a chromosome of the mammalian cell

Methodology Applied
Scientific EffectTransposition:

Data Source

PatentUS10358671B2Protein production method
Publication Date: 2019.07.23 KYOWA HAKKO KIRIN CO LTD
  • US10358671B2 patent drawing
  • US10358671B2 patent drawing
  • US10358671B2 patent drawing

AI summary

This invention relates to a method for producing a protein of interest, comprising introducing a protein expression vector which comprises a gene fragment a gene fragment comprising a DNA encoding a protein of interest and a selectable marker gene and transposon sequences at both terminals of the gene fragment, into a suspension mammalian cell; integrating the gene fragment inserted between a pair of the transposon sequences, into a chromosome of the mammalian cell to obtain a mammalian cell capable of expressing the protein of interest; and suspension-culturing the mammalian cell; and a suspension mammalian cell capable of expressing the protein of interest.